Are You an APN Searching for COG Supportive Care Guidelines? COG Guideline Development/Endorsement Process with Practical Applications (C234)

2:15 – 3:15 pm Saturday, September 15

coglogo 1CNE Since the 1970s survival rates for most types of pediatric cancer have continued to improve, with about 80% of patients now expected to become long-term survivors. However, this incredible success requires intensive treatments that are often associated with significant acute and long-term side effects. These side effects of pediatric cancer therapy can negatively impact a patient’s symptom experience and quality of life. Lack of effective symptom management can potentially impact outcomes through delays in proven curative treatments, dose reductions, and patient nonadherence to the treatment plan.

Many treatment-related symptoms, however, can be palliated, and a substantial body of evidence-based research exists to provide guidance regarding best practices for prevention and treatment of these symptoms. Advanced practice nurses (APN) often are the providers central to educating and counseling patients and families and prescribing treatments for symptom management. Clinical practice guidelines (CPGs) are rigorously-developed recommendations based on existing literature and synthesized through a well-defined process. The Children’s Oncology Group (COG) has created a committee tasked with identifying, appraising, and endorsing relevant and well-developed CPGs for the prevention and management of common side effects experienced by pediatric cancer patients receiving therapy on clinical trials. The purpose of this session will be to provide APNs with an overview of the guideline development process, introduce the current portfolio of COG-endorsed guidelines, and examine the practical application of these CPGs in pediatric oncology settings. Case scenarios will be woven throughout the session, and interactive teaching methods will be utilized.